Application of regorafenib to metastatic colorectal cancer patients in clinical practice; a retrospective study

被引：0
|
作者：
Kawai, Sadayuki [1 ]
Sakamoto, Yasuhiro [1 ]
Takahashi, Yoshikazu [1 ]
Ichikawa, Sonoko [1 ]
Gamoh, Makio [1 ]
机构：
[1] Osaki Citizen Hosp, Dept Med Oncol, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-5-9
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [41] TDM of Regorafenib in patients with metastatic colorectal cancer: preliminary results
    Beinse, G.
    Khoudour, N.
    Joly, C.
    Tournigand, C.
    Rousseau, B.
    Hulin, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 44 - 45
  • [42] A prospective, observational trial to assess the safety and efficacy of regorafenib in patients with metastatic colorectal cancer (mCRC) in routine clinical practice (CORRELATE)
    Michel, Ducreux
    Alfredo, Falcone
    Punt, Cornelis J. A.
    Svetlana, Kobina
    Juan Manuel, O'Connor
    Andres, Cervantes
    ANNALS OF ONCOLOGY, 2016, 27 : 80 - 80
  • [43] A prospective, observational trial to assess the safety and efficacy of regorafenib in patients with metastatic colorectal cancer (mCRC) in routine clinical practice (CORRELATE)
    Ducreux, M.
    Falcone, A.
    Punt, C. J. A.
    Majdi, A.
    O'Connor, J. M.
    Cervantes, A.
    ANNALS OF ONCOLOGY, 2015, 26
  • [44] Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Hamauchi, Satoshi
    Komori, Azusa
    Kito, Yosuke
    Narita, Yukiya
    Tsushima, Takahiro
    Ishihara, Makoto
    Todaka, Akiko
    Tanaka, Tsutomu
    Yokota, Tomoya
    Kadowaki, Shigenori
    Machida, Nozomu
    Ura, Takashi
    Fukutomi, Akira
    Ando, Masashi
    Onozawa, Yusuke
    Tajika, Masahiro
    Yasui, Hirofumi
    Muro, Kei
    Mori, Keita
    Yamazaki, Kentaro
    CLINICAL COLORECTAL CANCER, 2017, 16 (02) : E15 - E22
  • [45] Regorafenib dose modifications in patients with metastatic colorectal cancer in the phase III CORRECT study
    Falcone, A.
    Van Cutsem, E.
    Sobrero, A.
    Siena, S.
    Ychou, M.
    Lenz, H. J.
    Yoshino, T.
    Cihon, F.
    Wagner, A.
    Grothey, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S546 - S546
  • [46] Regorafenib plus tislelizumab for patients with metastatic colorectal cancer: A real-world study
    Gao, Xiang
    Chen, Xiaoping
    Zhao, Yutian
    Mao, Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [47] Regorafenib dose escalation therapy for patients with refractory metastatic colorectal cancer (RECC Study)
    Nakamura, Masato
    Yamada, Takeshi
    Ishiyama, Shun
    Enomoto, Masanobu
    Yokomizo, Hajime
    Kosugi, Chihiro
    Sonoda, Hiromichi
    Ishimaru, Kei
    Ishibashi, Keiichiro
    Kuramochi, Hidekazu
    Nozawa, Keijiro
    Ohta, Ryo
    Takahashi, Makoto
    Yoshida, Hiroshi
    Hashiguchi, Yojiro
    Hirata, Keiji
    Katsumata, Kenji
    Ishida, Hideyuki
    Koda, Keiji
    Sakamoto, Kazuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [48] Regorafenib dose modifications in patients with metastatic colorectal cancer in the phase III CORRECT study
    Karthaus, M.
    Falcone, A.
    van Cutsem, E.
    Sobrero, A.
    Siena, S.
    Ychou, M.
    Lenz, H. J.
    Yoshino, T.
    Cihon, F.
    Wagner, A.
    Grothey, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 39 - 39
  • [49] Regorafenib dose escalations in the prospective, observational CORRELATE study in patients with metastatic colorectal cancer
    Ducreux, M.
    O'Connor, J.
    Dochy, E.
    Fiala-Buskies, S.
    Cervantes, A.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2019, 30 : 119 - 119
  • [50] A retrospective cohort study evaluating the safety and efficacy of regorafenib in patients with metastatic colorectal cancer; The HGCSG1401 study - first report
    Dazai, M.
    Yuki, S.
    Muranaka, T.
    Yoshida, S.
    Ohta, Y.
    Hatanaka, K.
    Tsuji, Y.
    Ohta, T.
    Sato, A.
    Eto, K.
    Onodera, K.
    Sato, Y.
    Kato, K.
    Nakamura, M.
    Muto, O.
    Ishiguro, A.
    Tateyama, M.
    Okuda, H.
    Sakata, Y.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2015, 26 : 48 - 48
12345